CYPHERPUNK TECHNOLOGIES INC. Increase (Decrease) in Other Operating Assets
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Increase (Decrease) in Other Operating Assets of -$645.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-05-14
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was -$645.00K.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$980.00K.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$1.00K, a 114.29% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in other operating assets for the quarter ending 2025-06-30 was -$17.00K.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in other operating assets for fiscal 2025 was -$1.02M.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in other operating assets for fiscal 2024 was -$143.00K.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in other operating assets for fiscal 2023 was -$748.00K, a 199.07% decline from fiscal 2022.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in other operating assets for fiscal 2022 was $755.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$645.00K 10-Q · filed 2026-05-14 | -$1.63M derived: sum of 2 quarters · filed 2026-05-14 | -$1.63M derived: sum of 3 quarters · filed 2026-05-14 | -$1.64M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | -$980.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$981.00K derived: sum of 2 quarters · filed 2026-03-16 | -$998.00K derived: sum of 3 quarters · filed 2026-03-16 | -$1.02M 10-K · filed 2026-03-16 |
| 2025-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$18.00K derived: sum of 2 quarters · filed 2025-11-12 | -$40.00K 10-Q · filed 2025-11-12 | -$83.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$39.00K 10-Q · filed 2025-08-14 | -$82.00K derived: sum of 3 quarters · filed 2026-05-14 | -$75.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | -$22.00K 10-Q · filed 2026-05-14 | -$65.00K derived: sum of 2 quarters · filed 2026-05-14 | -$58.00K derived: sum of 3 quarters · filed 2026-05-14 | -$156.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$36.00K derived: sum of 2 quarters · filed 2026-03-16 | -$134.00K derived: sum of 3 quarters · filed 2026-03-16 | -$143.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$91.00K derived: sum of 2 quarters · filed 2025-11-12 | -$100.00K 10-Q · filed 2025-11-12 | -$47.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$107.00K 10-Q · filed 2025-08-14 | -$54.00K derived: sum of 3 quarters · filed 2025-08-14 | -$76.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$9.00K 10-Q · filed 2025-05-13 | $44.00K derived: sum of 2 quarters · filed 2025-05-13 | $22.00K derived: sum of 3 quarters · filed 2025-05-13 | -$34.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $31.00K derived: sum of 2 quarters · filed 2025-03-26 | -$25.00K derived: sum of 3 quarters · filed 2025-03-26 | -$748.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$78.00K derived: sum of 2 quarters · filed 2024-11-13 | -$801.00K 10-Q · filed 2024-11-13 | -$958.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$779.00K 10-Q · filed 2024-08-12 | -$936.00K derived: sum of 3 quarters · filed 2024-08-12 | $248.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$723.00K 10-Q · filed 2024-05-13 | -$880.00K derived: sum of 2 quarters · filed 2024-05-13 | $304.00K derived: sum of 3 quarters · filed 2024-05-13 | $48.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $1.03M derived: sum of 2 quarters · filed 2024-03-18 | $771.00K derived: sum of 3 quarters · filed 2024-03-18 | $755.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $928.00K derived: sum of 2 quarters · filed 2023-11-13 | $912.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$256.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$272.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$16.00K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | -$597.00K 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |